Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 175 participants.
Also called NCT02290080
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 175 participants
- Registry
-
NCT02290080
-
- Other papers using this trial's data
- Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial
- Supplemental oxygen therapy does not affect the systemic inflammatory response to acute myocardial infarction
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Sweden
- Registry status
- Completed
Technical summary
Registry record NCT02290080. Randomized; single masking; primary purpose treatment. Start 2014-10 (actual); primary completion 2015-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
- Acronym
- DETO2X-bio
- Condition
- Acute Myocardial Infarction (AMI)
- Condition
- Acute Coronary Syndrome (ACS)
- Condition
- ST Elevation (STEMI) Myocardial Infarction
- Condition
- Ischemic Reperfusion Injury
- Condition
- Non-ST Elevation (NSTEMI) Myocardial Infarction
- Condition
- Angina, Unstable
- Intervention (Drug)
- Oxygen
- Lead sponsor
- Karolinska Institutet
- Collaborator
- University Hospital, Linkoeping
Record details
- Record id
cardio:ct-nct02290080- Content hash
8f67b02e93d3e1a478f518da027a15f5336f582a72596ed94348c44ccc659ea8